IQVIA Holdings | IQV - Interest Income


IQVIA Holdings reported $13M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Accenture USD 106.22M 1.03M Sep/2025
Agilent USD 17M 1000K Sep/2025
Bruker USD 4.4M 1.5M Sep/2025
Celltrion KRW 676.66M 6.85B Jun/2025
Charles River Laboratories USD 1.1 1.1M Sep/2025
Cognizant Technology Solutions USD 25M 2M Sep/2025
Danaher USD 1.27 8M Sep/2025
Dentsply International USD 4M 1000K Mar/2025
Dianthus Therapeutics USD 3.66M 255K Sep/2025
Hologic USD 0.79 18.9M Dec/2025
IBM USD 150M 22M Sep/2025
Illumina USD 0.98 10M Sep/2025
Infosys INR 5.91B 0 Dec/2024
Kangmei Pharma CNY 1.81M 2.5M Jun/2025
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma EUR 139K 42K Jun/2025
Pharma Mar EUR 1.63M 3.17M Dec/2025
Qiagen NV USD 15.07M 1.21M Sep/2025
Quest Diagnostics USD 3M 1000K Sep/2025
Revvity USD 0.4 8.34M Sep/2025
Sartorius EUR 54.9M 77.1M Mar/2025
Thermo Fisher Scientific USD 4.27 297M Sep/2025
Tilray USD 12.83M 20.19M May/2024
Veradigm USD 1.7M 1.6M Sep/2022
Waters USD 2.5 4.51M Sep/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 6.65M 4.01M Jun/2025